Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
Sahrish QamarAnn D KingQi-Yong H AiFrankie Kwok Fai MoWeitian ChenDarren M C PoonMacy TongBrigette B MaDavid Ka-Wai YeungYi-Xiang WangJing YuanPublished in: European radiology (2020)
• APTw imaging may provide new markers to predict survival in nasopharyngeal carcinoma. • APT90 is an independent predictor of distant metastases-free survival and disease-free survival. • The APThigh group is at higher risk of disease relapse than the APTlow group.